The Ministry of Health and Welfare yesterday explained the main reasons for national drug shortages, and provided details regarding its short, medium and long-term strategies for handing the problem.
More than 14,000 types of drugs are included in the National Health Insurance system, with multiple reasons for some drug shortages, Deputy Minister of Health and Welfare Victor Wang (王必勝) said.
The primary reasons are connected to supply issues, including global drug shortages due to the COVID-19 pandemic, Russia’s invasion of Ukraine, shortages of drug ingredients and shipping delays, Wang said.
Photo: Lin Hui-chin, Taipei Times
As global demand increases and Taiwan is considered a small market by pharmaceutical companies, the quantity of imported drugs is likely to be affected, he said.
Another reason is “production issues,” including domestic drugmakers running low on raw materials, active ingredients and even workers, Wang said.
Clinical demand issues, such as an increase in demand for drugs for respiratory diseases during the winter, and long holidays also effect drug use, he said.
Other reasons include uneven distribution.
Hospitals are prioritized for drug deliveries, so the supply to local clinics and pharmacies often falls short, Wang said.
Many doctors are also accustomed to prescribing certain brands of drugs, despite having drugs of the same form, dosage and ingredients available, while higher prices also cause an issue, he added.
Wang said short-term solutions would be aimed at drugs that have no available alternative.
Negotiating with drug companies to increase production and quickly import new supplies, while evenly distributing drugs to healthcare facilities and hospitals would also be part of the ministry’s actions, Wang said.
The National Health Insurance Administration (NHIA) would also review and adjust its drug expenditure target (DET), he said.
Medium-term solutions include further adjusting the DET along with drug prices, establishing a permanent response center to monitor and deal with drug shortages faster, and setting up better communication channels with healthcare facilities and the public, Wang said.
Long-term solutions include re-evaluating the DET mechanism and drug price policies, encouraging and assisting drug companies in producing generic drugs, establishing a risk management mechanism and planning a national centralized procurement trial project, Wang said.
The Food and Drug Administration has established a drug supply information platform — dsms.fda.gov.tw — that allows healthcare providers and pharmacists to report shortages of drugs, he said.
NHIA Director-General Shih Chung-liang (石崇良) said that while many people are concerned that annual drug procurement price adjustments would make some drugs harder to obtain, the prices of drugs that are in short supply would not be adjusted.
ANOTHER EMERGES: The CWA yesterday said this year’s fourth storm of the typhoon season had formed in the South China Sea, but was not expected to affect Taiwan Tropical Storm Gaemi has intensified slightly as it heads toward Taiwan, where it is expected to affect the country in the coming days, the Central Weather Administration (CWA) said yesterday. As of 8am yesterday, the 120km-radius storm was 800km southeast of Oluanpi (鵝鑾鼻), Taiwan’s southernmost tip, moving at 9kph northwest, the agency said. A sea warning for Gaemi could be issued tonight at the earliest, it said, adding that the storm is projected to be closest to Taiwan on Wednesday or Thursday. Gaemi’s potential effect on Taiwan remains unclear, as that would depend on its direction, radius and intensity, forecasters said. Former Weather Forecast
As COVID-19 cases in Japan have been increasing for 10 consecutive weeks, people should get vaccinated before visiting the nation, the Centers for Disease Control (CDC) said. The centers reported 773 hospitalizations and 124 deaths related to COVID-19 in Taiwan last week. CDC Epidemic Intelligence Center Director Guo Hung-wei (郭宏偉) on Tuesday said the number of weekly COVID-19 cases reported in Japan has been increasing since mid-May and surpassed 55,000 cases from July 8 to July 14. The average number of COVID-19 patients at Japan’s healthcare facilities that week was also 1.39 times that of the week before and KP.3 is the dominant
The Chinese Communist Party’s (CCP) working group for Taiwan-related policies is likely to be upgraded to a committee-level body, a report commissioned by the Mainland Affairs Council (MAC) said. As Chinese President Xi Jinping (習近平) is increasingly likely to upgrade the CCP’s Central Leading Group for Taiwan Affairs, Taiwanese authorities should prepare by researching Xi and the CCP, the report said. At the third plenary session of the 20th Central Committee of the CCP, which ended on Thursday last week, the party set a target of 2029 for the completion of some tasks, meaning that Xi is likely preparing to
US-CHINA TRADE DISPUTE: Despite Beijing’s offer of preferential treatment, the lure of China has dimmed as Taiwanese and international investors move out Japan and the US have become the favored destinations for Taiwanese graduates as China’s attraction has waned over the years, the Ministry of Labor said. According to the ministry’s latest income and employment advisory published this month, 3,215 Taiwanese university graduates from the class of 2020 went to Japan, surpassing for the first time the 2,881 graduates who went to China. A total of 2,300 graduates from the class of 2021 went to the US, compared with the 2,262 who went to China, the document showed. The trend continued for the class of 2023, of whom 1,460 went to Japan, 1,334 went to